Lower Cholesterol:
Lower Cholesterol, High Cholesterol, Reduce Cholesterol, Articles on Cholesterol Management
-
Nov 5th, 2008
These natural plant substances when added in amounts of 2 to 3 grams can drop your LDL or “bad” cholesterol between 10 to 15 percent. High levels of LDL cholesterol contributes to fatty build up on artery walls which form plaque deposits narrowing the artery wall and diminishing blood flow.
-
Oct 28th, 2008
Statins, the class of drugs commonly used for lowering cholesterol, are now showing promise at preventing deep vein thrombosis (DVT) or blood clots, an affliction that occurs in nearly 2 million Americans each year.
-
Sep 30th, 2008
There is no link between cholesterol lowering drug statins and amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease, shows a new and long term study.
-
Sep 23rd, 2008
Using the drug darapladib, researchers have inhibited a cholesterol-and immune system-associated protein, thereby reducing the development of heart-disease plaques that may cause death, heart attacks, and strokes in a pig model of atherosclerosis and diabetes.
-
Sep 22nd, 2008
September is national Cholesterol Awareness Month, a good time to remind people that keeping cholesterol at healthy levels over a lifetime dramatically reduces one's risk of heart attack and stroke.
-
Sep 15th, 2008
Scientists in Oxford published data last week from the ongoing SHARP and IMPROVE-IT clinical trials, which shows no evidence for a link between cholesterol-lowering medication and an increased risk of cancer.
-
Sep 14th, 2008
Akira Endo wins The Lasker award for the discovery of the statins - drugs with remarkable LDL-cholesterol-lowering properties that have revolutionized the prevention and treatment of coronary heart disease.
-
Sep 4th, 2008
According to an editorial published in the New England Journal of Medicine, it is too early to rule out concerns about a possible Vytorin cancer connection that was identified in recent study data. The makers of Vytorin had previously sent a letter to healthcare providers dismissing the findings as likely attributed to chance.
-
Sep 1st, 2008
The long-term treatment of subjects with low HDL-C with the cholesteryl ester transfer protein (CETP) inhibitor Torcertapib. While Torcetrapib proved to have off-target toxic effects, two other CETP inhibitors (Anacetrapib and Delcetrapib) are being tested clinically. Experimentally, however, cholesteryl ester transfer protein inhibitors may not reduce atherosclerosis.
-
Sep 1st, 2008
Less cholesterol in your blood means you’re more likely to live a long and healthy life. O
